1 Introduction to Research & Analysis Reports |
1.1 Isoxsuprine Market Definition |
1.2 Market Segments |
1.2.1 Segment by Type |
1.2.2 Segment by Application |
1.3 China Isoxsuprine Market Overview |
1.4 Methodology & Sources of Information |
1.4.1 Research Methodology |
1.4.2 Research Process |
1.4.3 Base Year |
2 China Isoxsuprine Overall Market Size |
2.1 China Isoxsuprine Market Size: 2021 VS 2027 |
2.2 China Isoxsuprine Revenue, Prospects & Forecasts: 2016-2027 |
2.3 China Isoxsuprine Sales: 2016-2027 |
3 Company Landscape |
3.1 Top Isoxsuprine Players in China Market |
3.2 Top China Isoxsuprine Companies Ranked by Revenue |
3.3 China Isoxsuprine Revenue by Companies |
3.4 China Isoxsuprine Sales by Companies |
3.5 China Isoxsuprine Price by Manufacturer (2016-2021) |
3.6 Top 3 and Top 5 Isoxsuprine Companies in China Market, by Revenue in 2020 |
3.7 Manufacturers Isoxsuprine Product Type |
3.8 Tier 1, Tier 2 and Tier 3 Isoxsuprine Players in China Market |
3.8.1 List of Tier 1 Isoxsuprine Companies in China |
3.8.2 List of Tier 2 and Tier 3 Isoxsuprine Companies in China |
4 Sights by Type |
4.1 Overview |
4.1.1 By Type - China Isoxsuprine Market Size Markets, 2021 & 2027 |
4.1.2 Use in Humans |
4.1.3 Use in Animals |
4.2 By Type - China Isoxsuprine Revenue & Forecasts |
4.2.1 By Type - China Isoxsuprine Revenue, 2016-2021 |
轉(zhuǎn)自:http://www.szqimai.com/3/00/China-Isoxsuprine-Market-Research-and-Trends-Report-2021-2027.html |
4.2.2 By Type - China Isoxsuprine Revenue, 2022-2027 |
4.2.3 By Type - China Isoxsuprine Revenue Market Share, 2016-2027 |
4.3 By Type - China Isoxsuprine Sales & Forecasts |
4.3.1 By Type - China Isoxsuprine Sales, 2016-2021 |
4.3.2 By Type - China Isoxsuprine Sales, 2022-2027 |
4.3.3 By Type - China Isoxsuprine Sales Market Share, 2016-2027 |
4.4 By Type - China Isoxsuprine Price (Manufacturers Selling Prices), 2016-2027 |
5 Sights by Application |
5.1 Overview |
5.1.1 By Application - China Isoxsuprine Market Size, 2021 & 2027 |
5.1.2 Peripheral Vasodilator |
5.1.3 β-Sympathomimetic Agent |
5.2 By Application - China Isoxsuprine Revenue & Forecasts |
5.2.1 By Application - China Isoxsuprine Revenue, 2016-2021 |
5.2.2 By Application - China Isoxsuprine Revenue, 2022-2027 |
5.2.3 By Application - China Isoxsuprine Revenue Market Share, 2016-2027 |
5.3 By Application - China Isoxsuprine Sales & Forecasts |
5.3.1 By Application - China Isoxsuprine Sales, 2016-2021 |
5.3.2 By Application - China Isoxsuprine Sales, 2022-2027 |
5.3.3 By Application - China Isoxsuprine Sales Market Share, 2016-2027 |
5.4 By Application - China Isoxsuprine Price (Manufacturers Selling Prices), 2016-2027 |
6 Manufacturers & Brands Profiles |
6.1 Pharco |
6.1.1 Pharco Corporation Information |
6.1.2 Pharco Overview |
6.1.3 Pharco Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.1.4 Pharco Isoxsuprine Product Description |
6.1.5 Pharco Recent Developments |
6.2 Invision Pharma |
6.2.1 Invision Pharma Corporation Information |
6.2.2 Invision Pharma Overview |
6.2.3 Invision Pharma Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.2.4 Invision Pharma Isoxsuprine Product Description |
6.2.5 Invision Pharma Recent Developments |
6.3 Zenon Healthcare |
6.3.1 Zenon Healthcare Corporation Information |
6.3.2 Zenon Healthcare Overview |
6.3.3 Zenon Healthcare Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.3.4 Zenon Healthcare Isoxsuprine Product Description |
6.3.5 Zenon Healthcare Recent Developments |
6.4 Systemic |
6.4.1 Systemic Corporation Information |
6.4.2 Systemic Overview |
6.4.3 Systemic Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.4.4 Systemic Isoxsuprine Product Description |
6.4.5 Systemic Recent Developments |
6.5 Wockhardt |
6.5.1 Wockhardt Corporation Information |
6.5.2 Wockhardt Overview |
6.5.3 Wockhardt Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.5.4 Wockhardt Isoxsuprine Product Description |
6.5.5 Wockhardt Recent Developments |
6.6 Solvay Pharma |
6.6.1 Solvay Pharma Corporation Information |
6.6.2 Solvay Pharma Overview |
6.6.3 Solvay Pharma Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.6.4 Solvay Pharma Isoxsuprine Product Description |
6.6.5 Solvay Pharma Recent Developments |
6.7 Glenmark |
6.7.1 Glenmark Corporation Information |
6.7.2 Glenmark Overview |
6.7.3 Glenmark Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.7.4 Glenmark Isoxsuprine Product Description |
6.7.5 Glenmark Recent Developments |
2021-2027年中國異克蘇林市場研究與趨勢報(bào)告 |
6.8 Bristol-Myers Squibb |
6.8.1 Bristol-Myers Squibb Corporation Information |
6.8.2 Bristol-Myers Squibb Overview |
6.8.3 Bristol-Myers Squibb Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.8.4 Bristol-Myers Squibb Isoxsuprine Product Description |
6.8.5 Bristol-Myers Squibb Recent Developments |
6.9 Merck Sharp and Dohme |
6.9.1 Merck Sharp and Dohme Corporation Information |
6.9.2 Merck Sharp and Dohme Overview |
6.9.3 Merck Sharp and Dohme Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.9.4 Merck Sharp and Dohme Isoxsuprine Product Description |
6.9.5 Merck Sharp and Dohme Recent Developments |
6.10 Amriya |
6.10.1 Amriya Corporation Information |
6.10.2 Amriya Overview |
6.10.3 Amriya Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.10.4 Amriya Isoxsuprine Product Description |
6.10.5 Amriya Recent Developments |
6.11 Pfizer |
6.11.1 Pfizer Corporation Information |
6.11.2 Pfizer Overview |
6.11.3 Pfizer Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.11.4 Pfizer Isoxsuprine Product Description |
6.11.5 Pfizer Recent Developments |
6.12 Winston Pharma |
6.12.1 Winston Pharma Corporation Information |
6.12.2 Winston Pharma Overview |
6.12.3 Winston Pharma Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.12.4 Winston Pharma Isoxsuprine Product Description |
6.12.5 Winston Pharma Recent Developments |
6.13 Johnson and Johnson |
6.13.1 Johnson and Johnson Corporation Information |
6.13.2 Johnson and Johnson Overview |
6.13.3 Johnson and Johnson Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.13.4 Johnson and Johnson Isoxsuprine Product Description |
6.13.5 Johnson and Johnson Recent Developments |
6.14 Aspen Pharmacare |
6.14.1 Aspen Pharmacare Corporation Information |
6.14.2 Aspen Pharmacare Overview |
6.14.3 Aspen Pharmacare Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.14.4 Aspen Pharmacare Isoxsuprine Product Description |
6.14.5 Aspen Pharmacare Recent Developments |
6.15 Abbott |
6.15.1 Abbott Corporation Information |
6.15.2 Abbott Overview |
6.15.3 Abbott Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.15.4 Abbott Isoxsuprine Product Description |
6.15.5 Abbott Recent Developments |
6.16 Drugmaker's Laboratoires |
6.16.1 Drugmaker's Laboratoires Corporation Information |
6.16.2 Drugmaker's Laboratoires Overview |
6.16.3 Drugmaker's Laboratoires Isoxsuprine Sales and Revenue in China Market (2016-2021) |
6.16.4 Drugmaker's Laboratoires Isoxsuprine Product Description |
6.16.5 Drugmaker's Laboratoires Recent Developments |
7 China Isoxsuprine Production Capacity, Analysis |
7.1 China Isoxsuprine Production Capacity, 2016-2027 |
7.2 Isoxsuprine Production Capacity of Key Manufacturers in China Market |
8 Key Market Trends, Opportunity, Drivers and Restraints |
8.1 Market Opportunities & Trends |
8.2 Market Drivers |
8.3 Market Restraints |
9 Isoxsuprine Supply Chain Analysis |
9.1 Isoxsuprine Industry Value Chain |
9.2 Isoxsuprine Upstream Market |
2021-2027年中國異克蘇林市場研究與趨勢報(bào)告 |
9.3 Isoxsuprine Downstream and Clients |
9.4 Marketing Channels Analysis |
9.4.1 Marketing Channels |
9.4.2 Isoxsuprine Distributors and Sales Agents in China Market |
10 Conclusion |
11 Appendix |
11.1 Note |
11.2 Examples of Clients |
11.3 Author Details |
11.4 Disclaimer |
List of Tables |
Table 1. Key Players of Isoxsuprine in China Market |
Table 2. Top Isoxsuprine Players in China Market, Ranking by Revenue (2019) |
Table 3. China Isoxsuprine Revenue by Companies, (US$, Mn), 2016-2021 |
Table 4. China Isoxsuprine Revenue Share by Companies, 2016-2021 |
Table 5. China Isoxsuprine Sales by Companies, (K Units), 2016-2021 |
Table 6. China Isoxsuprine Sales Share by Companies, 2016-2021 |
Table 7. Key Manufacturers Isoxsuprine Price (2016-2021) & (US$/Unit) |
Table 8. Manufacturers Isoxsuprine Product Type |
Table 9. List of Tier 1 Isoxsuprine Companies, Revenue (US$, Mn) in 2020 and Market Share |
Table 10. List of Tier 2 and Tier 3 Isoxsuprine Companies, Revenue (US$, Mn) in 2020 and Market Share |
Table 11. Major Manufacturers of Use in Humans |
Table 12. Major Manufacturers of Use in Animals |
Table 13. By Type – China Isoxsuprine Revenue, (US$, Mn), 2021 & 2027 |
Table 14. By Type - China Isoxsuprine Revenue (US$, Mn), 2016-2021 |
Table 15. By Type - China Isoxsuprine Revenue (US$, Mn), 2022-2027 |
Table 16. By Type - China Isoxsuprine Sales (K Units), 2016-2021 |
Table 17. By Type - China Isoxsuprine Sales (K Units), 2022-2027 |
Table 18. By Application – China Isoxsuprine Revenue, (US$, Mn), 2021 VS 2027 |
Table 19. By Application - China Isoxsuprine Revenue (US$, Mn), 2016-2021 |
Table 20. By Application - China Isoxsuprine Revenue (US$, Mn), 2022-2027 |
Table 21. By Application - China Isoxsuprine Sales (K Units), 2016-2021 |
Table 22. By Application - China Isoxsuprine Sales (K Units), 2022-2027 |
Table 23. Pharco Corporation Information |
Table 24. Pharco Description and Major Businesses |
Table 25. Pharco Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 26. Pharco Isoxsuprine Product |
Table 27. Pharco Recent Developments |
Table 28. Invision Pharma Corporation Information |
Table 29. Invision Pharma Description and Major Businesses |
Table 30. Invision Pharma Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 31. Invision Pharma Isoxsuprine Product |
Table 32. Invision Pharma Recent Developments |
Table 33. Zenon Healthcare Corporation Information |
Table 34. Zenon Healthcare Description and Major Businesses |
Table 35. Zenon Healthcare Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 36. Zenon Healthcare Isoxsuprine Product |
Table 37. Zenon Healthcare Recent Developments |
Table 38. Systemic Corporation Information |
Table 39. Systemic Description and Major Businesses |
Table 40. Systemic Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 41. Systemic Isoxsuprine Product |
Table 42. Systemic Recent Developments |
Table 43. Wockhardt Corporation Information |
Table 44. Wockhardt Description and Major Businesses |
Table 45. Wockhardt Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 46. Wockhardt Isoxsuprine Product |
Table 47. Wockhardt Recent Developments |
Table 48. Solvay Pharma Corporation Information |
Table 49. Solvay Pharma Description and Major Businesses |
Table 50. Solvay Pharma Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 51. Solvay Pharma Isoxsuprine Product |
Table 52. Solvay Pharma Recent Developments |
Table 53. Glenmark Corporation Information |
2021-2027 Nian Zhong Guo Yi Ke Su Lin Shi Chang YanJiu Yu Qu Shi Bao Gao |
Table 54. Glenmark Description and Major Businesses |
Table 55. Glenmark Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 56. Glenmark Isoxsuprine Product |
Table 57. Glenmark Recent Developments |
Table 58. Bristol-Myers Squibb Corporation Information |
Table 59. Bristol-Myers Squibb Description and Major Businesses |
Table 60. Bristol-Myers Squibb Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 61. Bristol-Myers Squibb Isoxsuprine Product |
Table 62. Bristol-Myers Squibb Recent Developments |
Table 63. Merck Sharp and Dohme Corporation Information |
Table 64. Merck Sharp and Dohme Description and Major Businesses |
Table 65. Merck Sharp and Dohme Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 66. Merck Sharp and Dohme Isoxsuprine Product |
Table 67. Merck Sharp and Dohme Recent Developments |
Table 68. Amriya Corporation Information |
Table 69. Amriya Description and Major Businesses |
Table 70. Amriya Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 71. Amriya Isoxsuprine Product |
Table 72. Amriya Recent Developments |
Table 73. Pfizer Corporation Information |
Table 74. Pfizer Description and Major Businesses |
Table 75. Pfizer Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 76. Pfizer Isoxsuprine Product |
Table 77. Pfizer Recent Developments |
Table 78. Winston Pharma Corporation Information |
Table 79. Winston Pharma Description and Major Businesses |
Table 80. Winston Pharma Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 81. Winston Pharma Isoxsuprine Product |
Table 82. Winston Pharma Recent Developments |
Table 83. Johnson and Johnson Corporation Information |
Table 84. Johnson and Johnson Description and Major Businesses |
Table 85. Johnson and Johnson Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 86. Johnson and Johnson Isoxsuprine Product |
Table 87. Johnson and Johnson Recent Developments |
Table 88. Aspen Pharmacare Corporation Information |
Table 89. Aspen Pharmacare Description and Major Businesses |
Table 90. Aspen Pharmacare Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 91. Aspen Pharmacare Isoxsuprine Product |
Table 92. Aspen Pharmacare Recent Developments |
Table 93. Abbott Corporation Information |
Table 94. Abbott Description and Major Businesses |
Table 95. Abbott Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 96. Abbott Isoxsuprine Product |
Table 97. Abbott Recent Developments |
Table 98. Drugmaker's Laboratoires Corporation Information |
Table 99. Drugmaker's Laboratoires Description and Major Businesses |
Table 100. Drugmaker's Laboratoires Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
Table 101. Drugmaker's Laboratoires Isoxsuprine Product |
Table 102. Drugmaker's Laboratoires Recent Developments |
Table 103. Isoxsuprine Production Capacity (K Units) of Key Manufacturers in China Market, 2019-2021 (K Units) |
Table 104. China Isoxsuprine Capacity Market Share of Key Manufacturers, 2019-2021 |
Table 105. Isoxsuprine Market Opportunities & Trends in China Market |
Table 106. Isoxsuprine Market Drivers in China Market |
Table 107. Isoxsuprine Market Restraints in China Market |
Table 108. Isoxsuprine Raw Materials |
Table 109. Isoxsuprine Raw Materials Suppliers in China Market |
Table 110. Typical Isoxsuprine Downstream |
Table 111. Isoxsuprine Downstream Clients in China Market |
Table 112. Isoxsuprine Distributors and Sales Agents in China Market |
List of Figures |
Figure 1. Isoxsuprine Product Picture |
Figure 2. Isoxsuprine Segment by Type |
Figure 3. Isoxsuprine Segment by Application |
Figure 4. China Isoxsuprine Market Overview: 2020 |
中國イソクスプリンの市場調(diào)査と動向レポート2021-2027 |
Figure 5. China Isoxsuprine Market Size: 2021 VS 2027 (US$, Mn) |
Figure 6. China Isoxsuprine Revenue, 2016-2027 (US$, Mn) |
Figure 7. Isoxsuprine Sales in China Market: 2016-2027 (K Units) |
Figure 8. The Top 3 and 5 Players Market Share by Isoxsuprine Revenue in 2020 |
Figure 9. Use in Humans Product Picture |
Figure 10. Use in Animals Product Picture |
Figure 11. By Type - China Isoxsuprine Sales Market Share, 2016-2027 |
Figure 12. By Type - China Isoxsuprine Revenue Market Share, 2016-2027 |
Figure 13. By Type - China Isoxsuprine Price (US$/Unit), 2016-2027 |
Figure 14. Peripheral Vasodilator |
Figure 15. β-Sympathomimetic Agent |
Figure 16. By Application - China Isoxsuprine Sales Market Share, 2016-2027 |
Figure 17. By Application - China Isoxsuprine Revenue Market Share, 2016-2027 |
Figure 18. By Application - China Isoxsuprine Price (US$/Unit), 2016-2027 |
Figure 19. Pharco Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 20. Invision Pharma Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 21. Zenon Healthcare Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 22. Systemic Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 23. Wockhardt Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 24. Solvay Pharma Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 25. Glenmark Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 26. Bristol-Myers Squibb Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 27. Merck Sharp and Dohme Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 28. Amriya Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 29. Pfizer Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 30. Winston Pharma Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 31. Johnson and Johnson Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 32. Aspen Pharmacare Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 33. Abbott Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 34. Drugmaker's Laboratoires Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
Figure 35. China Isoxsuprine Production Capacity (K Units), 2016-2027 |
Figure 36. Isoxsuprine Industry Value Chain |
Figure 37. Marketing Channels |
http://www.szqimai.com/3/00/China-Isoxsuprine-Market-Research-and-Trends-Report-2021-2027.html
略……
如需購買《China Isoxsuprine Market Research and Trends Report 2021-2027》,編號:3180003
請您致電:400 612 8668、010-6618 1099、66182099、66183099
或Email至:KF@Cir.cn 【網(wǎng)上訂購】 ┊ 下載《訂購協(xié)議》 ┊ 了解“訂購流程”
請您致電:400 612 8668、010-6618 1099、66182099、66183099
或Email至:KF@Cir.cn 【網(wǎng)上訂購】 ┊ 下載《訂購協(xié)議》 ┊ 了解“訂購流程”